By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pathwork Diagnostics today announced it has received approval from the New York State Department of Health to offer its Tissue of Origin testing service.

As a result the Redwood, Calif., company will be able to offer the service, which it said is the only FDA-cleared tissue of origin testing service in New York state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.